Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype

被引:28
|
作者
Stevenson, DA [1 ]
Viskochil, DH [1 ]
Rope, AF [1 ]
Carey, JC [1 ]
机构
[1] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA
关键词
neurofibromatosis; Noonan syndrome; PTPN11; pulmonic stenosis;
D O I
10.1111/j.1399-0004.2006.00576.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis-Noonan syndrome (NFNS) has been described as a unique phenotype, combining manifestations of neurofibromatosis type 1 (NF1) and Noonan syndrome, which are separate syndromes. Potential etiologies of NFNS include a discrete syndrome of distinct etiology, co-segregation of two mutated common genes, variable clinical expressivity of NF1, and/or allelic heterogeneity. We present an informative family with an unusual NF1 mutation with variable features of NF1 and Noonan syndrome. We hypothesize that an NF1 mutant allele can lead to diagnostic manifestations of Noonan syndrome, supporting the hypothesis that NF1 allelic heterogeneity causes NFNS.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [41] Molecular diagnostics of neurofibromatosis type 1
    Kapitanovic, S
    PERIODICUM BIOLOGORUM, 1998, 100 (03) : 325 - 330
  • [42] Delineating the autistic phenotype in children with neurofibromatosis type 1
    Chisholm, Anita K.
    Haebich, Kristina M.
    Pride, Natalie A.
    Walsh, Karin S.
    Lami, Francesca
    Ure, Alex
    Maloof, Tiba
    Brignell, Amanda
    Rouel, Melissa
    Granader, Yael
    Maier, Alice
    Barton, Belinda
    Darke, Hayley
    Dabscheck, Gabriel
    Anderson, Vicki A.
    Williams, Katrina
    North, Kathryn N.
    Payne, Jonathan M.
    MOLECULAR AUTISM, 2022, 13 (01)
  • [43] Two hits in RAS/MAPK: a case report of dual molecular diagnoses of Neurofibromatosis type 1 and Noonan syndrome.
    Josephi-Taylor, Sarah
    Jones, Kristi
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1436 - 1437
  • [44] Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlation in neurofibromatosis type 1?
    Cnossen, MH
    vanderEst, MN
    Breuning, MH
    vanAsperen, CJ
    BreslauSiderius, EJ
    vanderPloeg, AT
    deGoedeBolder, A
    vandenOuweland, AMW
    Halley, DJJ
    Niermeijer, MF
    HUMAN MUTATION, 1997, 9 (05) : 458 - 464
  • [45] Clinical phenotype of South African children with neurofibromatosis 1
    Ramanjam, Veruschka
    Adnams, Colleen
    Ndondo, Alvin
    Fieggen, Graham
    Fieggen, Karen
    Wilmshurst, Jo
    JOURNAL OF CHILD NEUROLOGY, 2006, 21 (01) : 63 - 70
  • [46] Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype
    Bai, Zhuanli
    Qu, Yiping
    Shi, Lin
    Li, Xinju
    Yang, Zhen
    Ji, Meiju
    Hou, Peng
    CELL DEATH & DISEASE, 2021, 12 (08)
  • [47] Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype
    Zhuanli Bai
    Yiping Qu
    Lin Shi
    Xinju Li
    Zhen Yang
    Meiju Ji
    Peng Hou
    Cell Death & Disease, 12
  • [48] EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients
    Ricardo Ribeiro
    Ângelo Soares
    Daniela Pinto
    Raquel Catarino
    Carlos Lopes
    Rui Medeiros
    Journal of Neuro-Oncology, 2007, 81 : 225 - 229
  • [49] EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients
    Ribeiro, Ricardo
    Soares, Angelo
    Pinto, Daniela
    Catarino, Raquel
    Lopes, Carlos
    Medeiros, Rui
    JOURNAL OF NEURO-ONCOLOGY, 2007, 81 (03) : 225 - 229
  • [50] Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome
    Bahuau, M
    Houdayer, C
    Assouline, B
    Blanchet-Bardon, C
    Le Merrer, M
    Lyonnet, S
    Giraud, S
    Récan, D
    Lakhdar, H
    Vidaud, M
    Vidaud, D
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 75 (03): : 265 - 272